Published Articles & Presentations

Published Articles & Presentations

The information in our publications and presentations should be considered accurate only as of the date of the publications or presentations. We disclaim any obligation to supplement or update the information in these publications and presentations.

To learn more about our innovative technology:
Safety, Tolerability and Comparative Bioavailability of a Novel Intranasal DHE Product (INP104)

July 2018 - Migraine remains a serious cause of disability. Up to 42% of migraineurs still report dissatisfaction with their treatment, over a third (37%) with the speed of effect and half (50%) were dissatisfied that their pain recurred. Dihydroergotamine…

READ MORE

Impel NeuroPharma, Inc. SPECT Imaging of Direct Nose-to-Brain Transfer of MAG-3 in Man

Presented at AAPS 2013. Poster PDF

READ MORE

Impel NeuroPharma, Inc. Usability and Tolerability Study in Human Subjects with a Novel Precision Olfactory Delivery (POD) Device

Presented at AAPS 2013. Poster PDF

READ MORE